InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Meixelsperger Mary E, Chief Financial Officer. Officer active across 2 companies, notably GENESCO INC. Cumulatively, 11 filings have been recorded. Total volume traded: €481k. The latest transaction was filed on 23 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations11 total
02,067 shares0
Common Stock
SEC:0001209191-22-039263:0·
3,333 shares
Common Stock
SEC:0001674910-21-000138·
3,333 shares
Common Stock
SEC:0001674910-21-000138:0·
26,054 shares
Common Stock
SEC:0001674910-21-000120·
26,054 shares
Common Stock
SEC:0001674910-21-000120:0·
01,804 shares0
Common Stock
SEC:0001209191-21-048166·
01,804 shares0
Common Stock
SEC:0001209191-21-048166:0·
€240,3175,000 shares@ €48.06340.077% mcap100.0% of flow
Common stock
SEC:0001209191-21-037678·
Ideal exit: 28 Feb 2022 (T+270)
€240,3175,000 shares@ €48.06340.077% mcap50.0% of flow
Common stock
SEC:0001209191-21-037678:0·
Ideal exit: 28 Feb 2022 (T+270)
0168 shares0
Common Stock
SEC:0001209191-21-034759·
0168 shares0
Common Stock
SEC:0001209191-21-034759:0·
11 of 11 declarations
About Meixelsperger Mary E
Mary E. Meixelsperger is the Chief Financial Officer at GENESCO INC and VALVOLINE INC. She is responsible for financial management and financial strategy for the companies. Her role is essential in ensuring financial health and compliance with regulations.
